Skip to main content

Table 7 Vac-2 group: proportions of VAHL reports in age groups segmented using CHAID algorithm (Pv < 0.01)

From: Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation

  <64.35 (n = 105) >64.35 (n = 246) Pv
No HLN 31 (29.5%) 145 (58.9%) <0.01
Grade 1 VAHL 21 (20.0%) 35 (14.2%) 0.18
Grade 2 VAHL 25 (23.8%) 47 (19.1%) 0.32
Grade 3 VAHL 15 (14.3%) 10 (4.1%) <0.01
Grade 4 VAHL 13 (12.4%) 9 (3.7%) <0.01
  1. Categorical variables are reported as frequency and percentage